Loading...

Oruka Therapeutics, Inc.

ORKA•NASDAQ
Healthcare
Biotechnology
$76.39
$7.36(10.66%)
U.S. Market opens in 2h 53m

Oruka Therapeutics, Inc. (ORKA) Stock Overview

Explore Oruka Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio-38.90
EPS (TTM)$-1.85
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$48.64
3 Months$54.90
1 Year Target$19.12

ORKA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Oruka Therapeutics, Inc. (ORKA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 80.14, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $19.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.90 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.66%
5-Day Change
9.43%
1-Month Change
71.74%
3-Month Change
118.88%
6-Month Change
175.78%
Year-to-Date (YTD) Change
152.03%
1-Year Change
643.09%
3-Year Change
219.89%
5-Year Change
79.32%
All-Time (Max) Change
-100.00%

Contact Information

http://www.orukatx.com
203-554-7604
221 Crescent Street Building 23, Suite 105, Menlo Park, MA, NaN

Company Facts

28 Employees
IPO DateAug 8, 1997
CountryUS
Actively Trading

Frequently Asked Questions